Predictors of Treatment with Osteoporosis Medications After Recent Fragility Fractures in a Multinational Cohort of Postmenopausal Women

被引:77
作者
Greenspan, Susan L. [1 ]
Wyman, Allison [2 ]
Hooven, Frederick H. [2 ]
Adami, Silvano [3 ]
Gehlbach, Stephen [2 ]
Anderson, Frederick A., Jr. [2 ]
Boone, Steven [4 ]
Lacroix, Andrea Z. [5 ]
Lindsay, Robert [6 ]
Netelenbos, J. Coen [7 ]
Pfeilschifter, Johannes [8 ]
Silverman, Stuart [9 ]
Siris, Ethel S. [10 ]
Watts, Nelson B. [11 ]
机构
[1] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15213 USA
[2] Univ Massachusetts, Sch Med, Ctr Outcomes Res, Worcester, MA USA
[3] Univ Verona, Osped Verona, Dept Rheumatol, Valeggio Sul Mincio, Italy
[4] Katholieke Univ Leuven, Div Geriatr Med, Leuven Univ, Ctr Metab Bone Dis, Louvain, Belgium
[5] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[6] Helen Hayes Hosp, Reg Bone Ctr, W Haverstraw, NY USA
[7] Vrije Univ Amsterdam Med Ctr, Dept Endocrinol, Amsterdam, Netherlands
[8] Alfried Krupp Hosp, Dept Internal Med 3, Essen, Germany
[9] Univ Calif Los Angeles, David Geffen Sch Med, Dept Rheumatol, Los Angeles, CA 90095 USA
[10] Columbia Univ, Med Ctr, New York, NY USA
[11] Univ Cincinnati, Bone Hlth & Osteoporosis Ctr, Cincinnati, OH USA
关键词
osteoporosis; fracture; osteoporosis treatment; BONE-MINERAL DENSITY; QUALITY-OF-LIFE; SELF-REPORT; PRIMARY-CARE; OLDER WOMEN; DIAGNOSIS; SF-36; RISK; MEN; POPULATION;
D O I
10.1111/j.1532-5415.2011.03854.x
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
030301 [社会学]; 100201 [内科学];
摘要
OBJECTIVES: To determine the proportion of untreated women who reported receiving treatment after incident fracture and to identify factors that predict treatment across an international spectrum of individuals. DESIGN: Prospective observational study. Self-administered questionnaires were mailed at baseline and 1 year. SETTING: Multinational cohort of noninstitutionalized women recruited from 723 primary physician practices in 10 countries. PARTICIPANTS: Sixty thousand three hundred ninety-three postmenopausal women aged 55 and older were recruited with a 2:1 oversampling of women aged 65 and older. MEASUREMENTS: Data collected included participant demographics, medical history, fracture occurrence, medications, and risk factors for fracture. Anti-osteoporosis medications (AOMs) included estrogen, selective estrogen receptor modulators, bisphosphonates, calcitonin, parathyroid hormone, and strontium. RESULTS: After the first year of follow-up, 1,075 women reported an incident fracture. Of these, 17% had started AOM, including 15% of those with a single fracture and 35% with multiple fractures. Predictors of treatment included baseline calcium use (P =.01), baseline diagnosis of osteoporosis (P <.001), and fracture type (P <.001). In multivariable analysis, women taking calcium supplements at baseline (odds ratio (OR) = 1.67) and with a baseline diagnosis of osteoporosis (OR = 2.55) were more likely to be taking AOM. Hip fracture (OR = 2.61), spine fracture (OR = 6.61), and multiple fractures (OR = 3.79) were associated with AOM treatment. Age, global region, and use of high-risk medications were not associated with treatment. CONCLUSION: More than 80% of older women with new fractures were not treated, despite the availability of AOM. Important factors associated with treatment in this international cohort included diagnosis of osteoporosis before the incident fracture, spine fracture, and to a lesser degree, hip fracture. J Am Geriatr Soc 60:455-461, 2012.
引用
收藏
页码:455 / 461
页数:7
相关论文
共 28 条
[1]
Low frequency of treatment of osteoporosis among postmenopausal women following a fracture [J].
Andrade, SE ;
Majumdar, SR ;
Chan, KA ;
Buist, DSM ;
Go, AS ;
Goodman, M ;
Smith, DH ;
Platt, R ;
Gurwitz, JH .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (17) :2052-2057
[2]
[Anonymous], 2008, CLIN GUID PREV TREAT
[3]
The care gap in diagnosis and treatment of women with a fragility fracture [J].
Bessette, L. ;
Ste-Marie, L. -G. ;
Jean, S. ;
Davison, K. S. ;
Beaulieu, M. ;
Baranci, M. ;
Bessant, J. ;
Brown, J. P. .
OSTEOPOROSIS INTERNATIONAL, 2008, 19 (01) :79-86
[5]
Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women [J].
Bliuc, Dana ;
Nguyen, D. Nguyen ;
Milch, Vivienne E. ;
Nguyen, Tuan V. ;
Eisman, John A. ;
Center, Jacqueline R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (05) :513-521
[6]
Using the SF-36 and Euroqol on an elderly population [J].
Brazier, JE ;
Walters, SJ ;
Nicholl, JP ;
Kohler, B .
QUALITY OF LIFE RESEARCH, 1996, 5 (02) :195-204
[7]
VALIDATING THE SF-36 HEALTH SURVEY QUESTIONNAIRE - NEW OUTCOME MEASURE FOR PRIMARY CARE [J].
BRAZIER, JE ;
HARPER, R ;
JONES, NMB ;
OCATHAIN, A ;
THOMAS, KJ ;
USHERWOOD, T ;
WESTLAKE, L .
BMJ-BRITISH MEDICAL JOURNAL, 1992, 305 (6846) :160-164
[8]
EuroQol: The current state of play [J].
Brooks, R .
HEALTH POLICY, 1996, 37 (01) :53-72
[9]
POPULATION-BASED STUDY OF SURVIVAL AFTER OSTEOPOROTIC FRACTURES [J].
COOPER, C ;
ATKINSON, EJ ;
JACOBSEN, SJ ;
OFALLON, WM ;
MELTON, LJ .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1993, 137 (09) :1001-1005
[10]
Cooper C., 1997, AM J MED, V103, p17S, DOI DOI 10.1016/S0002-9343(97)90022-X